Literature DB >> 34390510

Prevalence of Parkinson's Disease: A Community-Based Study in China.

Shige Qi1, Peng Yin1, Linhong Wang1, Ming Qu2, Ge Lin Kan3, Han Zhang1, Qingjun Zhang4, Yize Xiao5, Ying Deng6, Zhong Dong7, Yan Shi8, Jun Meng9, Piu Chan10, Zhihui Wang1.   

Abstract

BACKGROUND: China's socioeconomic and population structures have evolved markedly during the past few decades, and consequently, monitoring the prevalence of Parkinson's disease (PD) is crucial.
OBJECTIVE: This study aimed to investigate the prevalence of PD within Chinese communities, particularly in older people.
METHODS: A nationwide study of 24,117 participants, aged 60 years or older, was carried out in 2015 using multistage clustered sampling. All participants were initially screened using a nine-item questionnaire, from which those suspected of having PD were examined by neurologists and a diagnosis was given, according to the 2015 Movement Disorder Society Clinical Diagnostic Criteria.
RESULTS: The prevalence of PD was 1.37% (95% confidence interval 1.02%-1.73%) in people aged over 60 years. Thus, the estimated total number of people in China with PD could be as high as 3.62 million.
CONCLUSIONS: Although the PD population prevalence percentage did not change significantly, the total number of PD sufferers has increased with the increased population, which poses a significant challenge in a rapidly aging population.
© 2021 International Parkinson and Movement Disorder Society. © 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; epidemiology; prevalence

Mesh:

Year:  2021        PMID: 34390510     DOI: 10.1002/mds.28762

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Long Non-coding RNA HOTAIR in Central Nervous System Disorders: New Insights in Pathogenesis, Diagnosis, and Therapeutic Potential.

Authors:  Jialu Wang; Jiuhan Zhao; Pan Hu; Lianbo Gao; Shen Tian; Zhenwei He
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

Review 2.  The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases.

Authors:  Chunyan Zhang; Xugang Kan; Baole Zhang; Haibo Ni; Jianfeng Shao
Journal:  Mol Brain       Date:  2022-10-22       Impact factor: 4.399

Review 3.  Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development.

Authors:  Sarah F McComish; Adina N MacMahon Copas; Maeve A Caldwell
Journal:  Front Neurosci       Date:  2022-05-16       Impact factor: 5.152

4.  Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.

Authors:  Yuanchu Zheng; Zhenwei Yu; Jiajia Zhao; Huihui Cai; Zhan Wang; Xuemei Wang; Tao Feng
Journal:  Front Aging Neurosci       Date:  2022-03-28       Impact factor: 5.750

5.  Association Between Drinking Water Sources and Osteoarthritis Incidence in Chinese Elderly Population: National Population-Based Cohort Study.

Authors:  Yangchang Zhang; Tingting Wu; Shisi Shen; Yang Xiong; Xu Wang; Jialu Yang; Xirui Chen; Yanjun Lu; Xun Lei
Journal:  Front Med (Lausanne)       Date:  2022-02-03

6.  The quality of life in patients with Parkinson's disease: Focus on gender difference.

Authors:  Detao Meng; Zhaohui Jin; Lei Gao; Yixuan Wang; Ruidan Wang; Jinping Fang; Lin Qi; Yuan Su; Aixian Liu; Boyan Fang
Journal:  Brain Behav       Date:  2022-02-09       Impact factor: 2.708

7.  Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells.

Authors:  Jingwangwei Liu; Yujia Lu; Min Tang; Fanghao Shao; Dongzi Yang; Shuchang Chen; Ziyi Xu; Leilei Zhai; Juanjuan Chen; Qian Li; Wei Wu; Haimin Chen
Journal:  Mar Drugs       Date:  2022-03-31       Impact factor: 6.085

Review 8.  Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.

Authors:  Manlian Zhu; Xia Liu; Yiru Ye; Xiumei Yan; Yiwen Cheng; Longyou Zhao; Feng Chen; Zongxin Ling
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

9.  Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.

Authors:  Hui Zhang; Wenjing Zhou; Donglan Zhang
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.